THE IMPACT OF METABOLIC RISK FACTORS, DIABETES, MEDICATIONS AND COMORBID ILLNESS ON TRANSIT TIME AT CAPSULE ENDOSCOPY: A PROSPECTIVE COHORT STUDY

Robert Cheng,Nak-Jin Choi,Suhirdan Vivekanandarajah,Shehan Abey,Jenny McDonald,Milan S Bassan
DOI: https://doi.org/10.2174/2666290601666220303123827
2022-03-03
The International Journal of Gastroenterology and Hepatology Diseases
Abstract:Background: Video capsule endoscopy (VCE) is a safe and effective way of investigating obscure gastrointestinal bleeding. One of the main limitations of VCE is suboptimal visualisation due to prolonged gastric transit time (GTT) or rapid small intestinal transit time (SITT). The role of metabolic risk factors, diabetes, and medications on transit times remains unclear. Aim: The aim of this study was to assess the impact of diabetes, obesity, medications, and metabolic syndrome on transit times at VCE. Method: The study performed was a single centre, observational study. Results: Significant predictors of decreased GTT were increasing age and use of beta blocker medication. No predictive factors for increased GTT were identified. Significant predictors of decreased SITT on univariate analysis were increasing GTT, serum glucose >5mmol/L, obesity, and diabetes. On multivariate analysis increasing GTT and increased glucose remained significant. Conclusions: Beta-blocker therapy reduces GTT. Hyperglycaemia at the time of VCE reduces SITT. These allow for possible therapeutic strategies to improve the diagnostic yield at VCE.
What problem does this paper attempt to address?